Michael Dybbs, Director at Dimension Therapeutics, Inc. (DMTX), bought 2,059,283 shares at $13.00 ($12.5M) on 2015-10-27, disclosed to the SEC on 2015-10-29.
Open-market purchase of $12.5M DMTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,097,745 | $0 | 0.0% |
| 2 | $13.00 | 961,538 | $12.5M | 100.0% |
| Total | $6.07 avg | 2,059,283 | $12.5M | 100% |